Navigation Links
Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
Date:5/15/2008

Randomized TRIAS HR Pilot Study Compares Genous, Boston Scientific's

Taxus(R) Other Presentations Focus on Real-World Use of Genous, Stent's Performance

in Patients with AMI, Those Who Could Not Tolerate Dual-Antiplatelet

Therapy

BARCELONA, Spain, May 15 /PRNewswire/ -- OrbusNeich today announced that multiple clinical data presentations in a symposium at EuroPCR 2008 support the use of the company's Genous Bio-engineered R stent, the world's first pro-healing stent, as a safe alternative to drug-eluting stents.

12-Month TRIAS HR Pilot Study Data

Presented by Robbert de Winter, M.D., Ph.D., of the Academic Medical Center in Amsterdam, data from the TRIAS HR (high risk) Pilot study show similar target vessel failure (TVF) rates at 12-month follow-up for OrbusNeich's Genous Bio-engineered R stent and Boston Scientific's Taxus stent in high risk of restenosis patients.

In the patients treated with Taxus, there were four out-of-hospital thrombotic events, while there were no reported events in the Genous group. TRIAS HR Pilot is a randomized, 193-patient, single-center, prospective, single-blind study involving patients with a high risk of restenosis. High risk of restenosis is defined as patients who have diabetes mellitus and/or small vessels (less than 2.8 mm) and/or long lesions (greater than 23 mm) and/or chronic total occlusions.

"Interventional cardiologists need better stent technologies," said de Winter, principal investigator of the TRIAS HR Pilot study. "A pro-healing approach with the Genous stent is a viable one. We look forward to obtaining further data on the stent's performance in our large, multi-center TRIAS trials that compare Genous to both drug-eluting and bare metal stents."

e-HEALING Interim Patient Subset Data

In addition, de Winter presented interim follow-up data from patient subsets of e-HEALING, a monitored, m
'/>"/>

SOURCE OrbusNeich
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 06, 2015 Research and Markets ... the "Cannulas Market by Product (Nasal, Arterial, ... Microcannula), Material (Plastic, Metal) & End Users (Hospitals, ... report to their offering. The ... a CAGR of 5.6% from 2015 to 2020 ...
(Date:5/6/2015)... South Africa , May 6, ... kills more people than HIV/AIDS, malaria and tuberculosis combined[1]. Approximately ... percent can be cured with the right treatment[3]. Together with ... are working to build up their radiation therapy infrastructures and ... cancer patients worldwide would benefit from radiation therapy[4] during the ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4fgrnh/asiapacific ) ... Internal Trauma Fixation Devices Market by Type & ... report to their offering. The ... to grow at a CAGR of 6.7% from ... rising incidences of road accidents, increasing aging population, ...
Breaking Medicine Technology:Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2
(Date:5/6/2015)... OH (PRWEB) May 06, 2015 Anitha ... at Hematology Oncology Consultants, Inc. in Columbus, OH. ... and has a special focus in breast cancer, lung cancer, ... and lymphoma as well as benign hematology. , ... and internal medicine by the American Board of Internal Medicine. ...
(Date:5/6/2015)... 2015 Wolters Kluwer , a ... students, announced today that in a survey of nearly ... of the clinical decision support resource improves the quality ... 2014, UpToDate users in more than 170 countries worldwide ... on average. In Germany alone, 95% of all university ...
(Date:5/6/2015)... 2015 Healthcare jobs platform, ... launching in mid-February. The company connects hospitals, home-health, and ... experience in the industry. Likewise, job seekers are able ... Kyle Johnson, CTO, unique traffic to the site is ... "Each new job posting brings targeted, interested candidates to ...
(Date:5/6/2015)... Locally owned, Greek olive oil producer and importer, ... as having one the best Extra Virgin Olive Oils in ... region of Greece and known as Laconiko , received ... Medium Olive Oil, which is defined by the competition as ... 700 producer applicants from 25 different countries applying, Laconiko stood ...
(Date:5/6/2015)... York (PRWEB) May 06, 2015 Dr. Vito ... facial plastic surgeons , recently completed a medical mission trip ... surgery on those affected by microtia and other deformities ... on April 17 and ended on April 26, Dr. Quatela ... patients. Microtia is a congenital deformity where the outside of ...
Breaking Medicine News(10 mins):Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 3
... insoles can jumpstart the nervous system into action. A new ... people maintain better balance. They proved most effective in elderly ... balance and reduce the number of falls and bone fractures. ... 12 older people. The theory is small vibrations should stimulate ...
... to accelerate death in many people, but previous research has ... ,A new study focuses on depression in elderly people living ... homes. ,The study, involved 250 participants in a community ... the presence of depression and then did so again at ...
... to an increased risk of liver disease. ,Chronic liver ... of death in the United States. Drug use and high-risk ... abuse and hepatitis are both causes of liver disease. The ... risky behavior in adulthood and therefore, increase the risk of ...
... makes its way into the human system when eaten -- and ... ,The compound, called sialic acid, is found on the surfaces of ... one reason why animal-to-human organ and tissue transplants do not work ... ,But researchers at have found it does show up in ...
... elderly women with chronic diseases may be at risk for experiencing ... 60 and 79. The women were asked if they // had ... fallen, and whether they received any medical attention for the falls. ... interview and gave a full drug history report. ,Results ...
... genetically modified rat models of greater predictability and quality. ... to the development of innovative therapeutics for major pathologies ... disorders. ,Rats and mice used in labs ... -- such as a weak immune system, or a ...
Cached Medicine News:Health News:Same molecule found in meat, milk, tumors 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: